Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0002041181-25-000001
Filing Date
2025-05-06
Accepted
2025-05-06 13:24:25
Documents
1
Effectiveness Date
2025-05-06
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 15958
  Complete submission text file 0002041181-25-000001.txt   17141
Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 212-739-6400
OrbiMed Royalty & Credit Opportunities V, LP (Filer) CIK: 0002041181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-529419 | Film No.: 25916451